Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent

Katherine E. Hanlon, Alysia N. Lozano-Ondoua, Puja J. Umaretiya, Ashley M. Symons-Liguori, Anupama Chandramouli, Jamie K. Moy, William K. Kwass, Patrick W. Mantyh, Mark A. Nelson, Todd W. Vanderah

Research output: Research - peer-reviewArticle

Abstract

Introduction: Cannabinoid compounds, both nonspecific as well as agonists selective for either cannabinoid receptor 1 (CB1) or cannabinoid receptor 2 (CB2), have been shown to modulate the tumor microenvironment by inducing apoptosis in tumor cells in several model systems. The mechanism of this modulation remains only partially delineated, and activity induced via the CB1 and CB2 receptors may be distinct despite significant sequence homology and structural similarity of ligands. Methods: The CB2-selective agonist JWH-015 was used to investigate mechanisms downstream of CB2 activation in mouse and human breast cancer cell lines in vitro and in a murine mammary tumor model. Results: JWH-015 treatment significantly reduced primary tumor burden and metastasis of luciferase-tagged murine mammary carcinoma 4T1 cells in immunocompetent mice in vivo. Furthermore, JWH-015 reduced the viability of murine 4T1 and human MCF7 mammary carcinoma cells in vitro by inducing apoptosis. JWH-015-mediated reduction of breast cancer cell viability was not dependent on Gαi signaling in vitro or modified by classical pharmacological blockade of CB1, GPR55, TRPV1, or TRPA1 receptors. JWH-015 effects were calcium dependent and induced changes in MAPK/ERK signaling. Conclusion: The results of this work characterize the actions of a CB2-selective agonist on breast cancer cells in a syngeneic murine model representing how a clinical presentation of cancer progression and metastasis may be significantly modulated by a G-protein-coupled receptor.

LanguageEnglish (US)
Pages59-71
Number of pages13
JournalBreast Cancer: Targets and Therapy
Volume8
DOIs
StatePublished - Apr 15 2016
Externally publishedYes

Fingerprint

Cannabinoid Receptor Agonists
Cell Survival
Breast Neoplasms
Calcium
JHW 015
In Vitro Techniques
Cannabinoid Receptors
Apoptosis
Neoplasm Metastasis
Neoplasms
Tumor Microenvironment
Cannabinoids
Sequence Homology
G-Protein-Coupled Receptors
Tumor Burden
Luciferases
Pharmacology
Ligands
Cell Line

Keywords

  • Apoptosis
  • Breast cancer
  • Calcium
  • Cannabinoid receptor-2
  • CB
  • JWH-015
  • MAPK/ERK

ASJC Scopus subject areas

  • Oncology

Cite this

Hanlon, K. E., Lozano-Ondoua, A. N., Umaretiya, P. J., Symons-Liguori, A. M., Chandramouli, A., Moy, J. K., ... Vanderah, T. W. (2016). Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. Breast Cancer: Targets and Therapy, 8, 59-71. DOI: 10.2147/BCTT.S100393

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. / Hanlon, Katherine E.; Lozano-Ondoua, Alysia N.; Umaretiya, Puja J.; Symons-Liguori, Ashley M.; Chandramouli, Anupama; Moy, Jamie K.; Kwass, William K.; Mantyh, Patrick W.; Nelson, Mark A.; Vanderah, Todd W.

In: Breast Cancer: Targets and Therapy, Vol. 8, 15.04.2016, p. 59-71.

Research output: Research - peer-reviewArticle

Hanlon, KE, Lozano-Ondoua, AN, Umaretiya, PJ, Symons-Liguori, AM, Chandramouli, A, Moy, JK, Kwass, WK, Mantyh, PW, Nelson, MA & Vanderah, TW 2016, 'Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent' Breast Cancer: Targets and Therapy, vol 8, pp. 59-71. DOI: 10.2147/BCTT.S100393
Hanlon KE, Lozano-Ondoua AN, Umaretiya PJ, Symons-Liguori AM, Chandramouli A, Moy JK et al. Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. Breast Cancer: Targets and Therapy. 2016 Apr 15;8:59-71. Available from, DOI: 10.2147/BCTT.S100393
Hanlon, Katherine E. ; Lozano-Ondoua, Alysia N. ; Umaretiya, Puja J. ; Symons-Liguori, Ashley M. ; Chandramouli, Anupama ; Moy, Jamie K. ; Kwass, William K. ; Mantyh, Patrick W. ; Nelson, Mark A. ; Vanderah, Todd W./ Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. In: Breast Cancer: Targets and Therapy. 2016 ; Vol. 8. pp. 59-71
@article{3666d298ac794131919e482f1ab27f69,
title = "Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent",
abstract = "Introduction: Cannabinoid compounds, both nonspecific as well as agonists selective for either cannabinoid receptor 1 (CB1) or cannabinoid receptor 2 (CB2), have been shown to modulate the tumor microenvironment by inducing apoptosis in tumor cells in several model systems. The mechanism of this modulation remains only partially delineated, and activity induced via the CB1 and CB2 receptors may be distinct despite significant sequence homology and structural similarity of ligands. Methods: The CB2-selective agonist JWH-015 was used to investigate mechanisms downstream of CB2 activation in mouse and human breast cancer cell lines in vitro and in a murine mammary tumor model. Results: JWH-015 treatment significantly reduced primary tumor burden and metastasis of luciferase-tagged murine mammary carcinoma 4T1 cells in immunocompetent mice in vivo. Furthermore, JWH-015 reduced the viability of murine 4T1 and human MCF7 mammary carcinoma cells in vitro by inducing apoptosis. JWH-015-mediated reduction of breast cancer cell viability was not dependent on Gαi signaling in vitro or modified by classical pharmacological blockade of CB1, GPR55, TRPV1, or TRPA1 receptors. JWH-015 effects were calcium dependent and induced changes in MAPK/ERK signaling. Conclusion: The results of this work characterize the actions of a CB2-selective agonist on breast cancer cells in a syngeneic murine model representing how a clinical presentation of cancer progression and metastasis may be significantly modulated by a G-protein-coupled receptor.",
keywords = "Apoptosis, Breast cancer, Calcium, Cannabinoid receptor-2, CB, JWH-015, MAPK/ERK",
author = "Hanlon, {Katherine E.} and Lozano-Ondoua, {Alysia N.} and Umaretiya, {Puja J.} and Symons-Liguori, {Ashley M.} and Anupama Chandramouli and Moy, {Jamie K.} and Kwass, {William K.} and Mantyh, {Patrick W.} and Nelson, {Mark A.} and Vanderah, {Todd W.}",
year = "2016",
month = "4",
doi = "10.2147/BCTT.S100393",
volume = "8",
pages = "59--71",
journal = "Breast Cancer: Targets and Therapy",
issn = "1179-1314",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent

AU - Hanlon,Katherine E.

AU - Lozano-Ondoua,Alysia N.

AU - Umaretiya,Puja J.

AU - Symons-Liguori,Ashley M.

AU - Chandramouli,Anupama

AU - Moy,Jamie K.

AU - Kwass,William K.

AU - Mantyh,Patrick W.

AU - Nelson,Mark A.

AU - Vanderah,Todd W.

PY - 2016/4/15

Y1 - 2016/4/15

N2 - Introduction: Cannabinoid compounds, both nonspecific as well as agonists selective for either cannabinoid receptor 1 (CB1) or cannabinoid receptor 2 (CB2), have been shown to modulate the tumor microenvironment by inducing apoptosis in tumor cells in several model systems. The mechanism of this modulation remains only partially delineated, and activity induced via the CB1 and CB2 receptors may be distinct despite significant sequence homology and structural similarity of ligands. Methods: The CB2-selective agonist JWH-015 was used to investigate mechanisms downstream of CB2 activation in mouse and human breast cancer cell lines in vitro and in a murine mammary tumor model. Results: JWH-015 treatment significantly reduced primary tumor burden and metastasis of luciferase-tagged murine mammary carcinoma 4T1 cells in immunocompetent mice in vivo. Furthermore, JWH-015 reduced the viability of murine 4T1 and human MCF7 mammary carcinoma cells in vitro by inducing apoptosis. JWH-015-mediated reduction of breast cancer cell viability was not dependent on Gαi signaling in vitro or modified by classical pharmacological blockade of CB1, GPR55, TRPV1, or TRPA1 receptors. JWH-015 effects were calcium dependent and induced changes in MAPK/ERK signaling. Conclusion: The results of this work characterize the actions of a CB2-selective agonist on breast cancer cells in a syngeneic murine model representing how a clinical presentation of cancer progression and metastasis may be significantly modulated by a G-protein-coupled receptor.

AB - Introduction: Cannabinoid compounds, both nonspecific as well as agonists selective for either cannabinoid receptor 1 (CB1) or cannabinoid receptor 2 (CB2), have been shown to modulate the tumor microenvironment by inducing apoptosis in tumor cells in several model systems. The mechanism of this modulation remains only partially delineated, and activity induced via the CB1 and CB2 receptors may be distinct despite significant sequence homology and structural similarity of ligands. Methods: The CB2-selective agonist JWH-015 was used to investigate mechanisms downstream of CB2 activation in mouse and human breast cancer cell lines in vitro and in a murine mammary tumor model. Results: JWH-015 treatment significantly reduced primary tumor burden and metastasis of luciferase-tagged murine mammary carcinoma 4T1 cells in immunocompetent mice in vivo. Furthermore, JWH-015 reduced the viability of murine 4T1 and human MCF7 mammary carcinoma cells in vitro by inducing apoptosis. JWH-015-mediated reduction of breast cancer cell viability was not dependent on Gαi signaling in vitro or modified by classical pharmacological blockade of CB1, GPR55, TRPV1, or TRPA1 receptors. JWH-015 effects were calcium dependent and induced changes in MAPK/ERK signaling. Conclusion: The results of this work characterize the actions of a CB2-selective agonist on breast cancer cells in a syngeneic murine model representing how a clinical presentation of cancer progression and metastasis may be significantly modulated by a G-protein-coupled receptor.

KW - Apoptosis

KW - Breast cancer

KW - Calcium

KW - Cannabinoid receptor-2

KW - CB

KW - JWH-015

KW - MAPK/ERK

UR - http://www.scopus.com/inward/record.url?scp=84964792151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964792151&partnerID=8YFLogxK

U2 - 10.2147/BCTT.S100393

DO - 10.2147/BCTT.S100393

M3 - Article

VL - 8

SP - 59

EP - 71

JO - Breast Cancer: Targets and Therapy

T2 - Breast Cancer: Targets and Therapy

JF - Breast Cancer: Targets and Therapy

SN - 1179-1314

ER -